Monashee Investment Management’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATIP.WS
FIG
ICM
LP
SCC
MCM
PFM
ICMH
Monashee Investment Management's ATIP.WS Position: Q4 2021 in Review
Monashee Investment Management sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q4 2021, closing a stake of 49,999 shares — an estimated $33K sold.
Monashee Investment Management first reported a position in ATIP.WS in Q2 2021 and held it in 2 quarters. The position peaked at $113K in Q2 2021. 22 funds tracked by Wall St. Rank hold ATIP.WS as of Q4 2021.
- Monashee Investment Management reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
- Monashee Investment Management sold 49,999 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2021, an estimated $33K.
- Monashee Investment Management first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
- Monashee Investment Management's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $113K in Q2 2021.
- 22 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2021.
Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.